Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

  • Tiziano Barbui
  • , Valerio De Stefano
  • , Alessandra Carobbio
  • , Alessandra Iurlo
  • , Alberto Alvarez-Larran
  • , Beatriz Cuevas
  • , Francisca Ferrer Marín
  • , Alessandro M. Vannucchi
  • , Francesca Palandri
  • , Claire Harrison
  • , Hassan Sibai
  • , Martin Griesshammer
  • , Massimiliano Bonifacio
  • , Elena M. Elli
  • , Chiara Trotti
  • , Steffen Koschmieder
  • , Giuseppe Carli
  • , Giulia Benevolo
  • , Jean-Christophe Ianotto
  • , Swati Goel
  • Anna Falanga, Silvia Betti, Daniele Cattaneo, Eduardo Arellano-Rodrigo, Lara Mannelli, Nicola Vianelli, Andrew Doyle, Vikas Gupta, Kai Wille, Douglas Tremblay, John Mascarenhas

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2989-2993
Number of pages5
JournalLeukemia
Volume35
DOIs
Publication statusPublished - 2021

Keywords

  • Direct Oral Anticoagulants
  • Myeloproliferative Neoplasms

Cite this